About Coeur Inc
Coeur Inc is a company based in Lebanon (United States) founded in 2003 was acquired by Illinois Tool Works in July 2013. Coeur Inc operates in a competitive market with competitors including Insulet, Lyra Therapeutics, TriSalus Life Sciences, Credence MedSystems and Cellectar Biosciences, among others.
- Headquarter Lebanon, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Illinois Tool Works
& 1 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Coeur Inc
Detailed funding history for Coeur Inc
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Coeur Inc
Coeur Inc has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Illinois Tool Works and The Riverside Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and debt are provided to middle market companies.
|
Locked | Locked | Locked | |
|
Major auto components are manufactured and supplied to OEMs.
|
Locked | Locked | Locked |
Investor details for Coeur Inc
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Coeur Inc
Investment portfolio details for Coeur Inc
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Coeur Inc
Detailed financials for Coeur Inc
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Coeur Inc Comparisons
Peer comparison for Coeur Inc
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Coeur Inc
Coeur Inc operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insulet, Lyra Therapeutics, TriSalus Life Sciences, Credence MedSystems and Cellectar Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for ENT diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of drug delivery devices to treat cancers
|
|
| Locked | Locked | Locked |
Developer of smart devices for drug delivery
|
|
| Locked | Locked | Locked |
Phospholipid drug conjugates for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Oligonucleotide delivery systems are developed for targeted gene therapy.
|
Detailed competitors of Coeur Inc
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Coeur Inc
Complete news archive for Coeur Inc
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Coeur Inc
Coeur Inc was founded in 2003.
Coeur Inc is headquartered in Lebanon, United States.
Coeur focuses on the manufacturing of single-use, disposable products for the imaging market. The company has developed CT and Angiographic power syringes and fluid delivery products, such as the Liebel-Flarsheim and MEDRAD injectors. The company received FDA 510(k) clearance in August 2017 (K170431) for its CT Syringe For Stellant Injectors (With Without Spikes, Prime Tubes, Fill Tubes), CT Syringe Dual Pack For Stellant Injectors (With Without Spikes, Prime Tubes, Fill Tubes), Single Fascia And Ram Tip, Dual Fascia And Ram Tip.
Coeur Inc's top competitors include Insulet, Lyra Therapeutics and Halozyme.
Coeur Inc has 2 investors. Key investors include Illinois Tool Works, and The Riverside Company.